Healthy Nevada Project Participants Start Receiving Incidental Findings Following Exome Sequencing

Oct 03, 2018

|

Premium

NEW YORK (GenomeWeb) – The Renown Institute for Health Innovation this week began returning genetic test results for familial hypercholesterolemia to participants in its Healthy Nevada Project, and in the coming months will report results for hereditary breast and ovarian cancer and Lynch syndrome.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Breaking News

The Scan

Genes at the Mall Near You?

23andMe has a holiday popup shop at a mall and could open additional stores, Bloomberg reports.

Koalas' Retroviral Response

By studying koalas and a retrovirus that infects them, researchers may have uncovered a new sort of 'immune response' that occurs at the genomic level, Agence France Presse reports.

Bound for Home

NPR reports that the first person in the US given a gene editing-based therapy for a genetic disorder is heading home.

Science Paper Peers into Ancient Social Inequality Within Households

In Science this week: ancient genomes reveal social inequality within individual households, new method for quantifying genetic variation in gene dosage, and more.

Oct

23

Featured Webinar

Single-Cell Methylation Profiling of Pediatric Tumors via a Unique NGS-based Approach

This webinar will illustrate how single-cell methylation sequencing can be applied to gain significant insight into epigenetic heterogeneity in disease states, advancing cancer research discoveries.

Menu